David Mulder Sample Contracts

SEC Documents
Filings
Personal financials
Insider transactions
Previous Companies
other: Former Director and CEO until September 30th, 2010
Biolase Technology Inc – SEPARATION AND GENERAL RELEASE AGREEMENT (November 3rd, 2010)

This Separation and General Release Agreement (this “Agreement”) is being entered into as of this 24th day of August, 2010, by and between Biolase Technology, Inc. (the “Company”), and David M. Mulder, an individual (“Employee”) (each of the Company and Employee is sometimes hereinafter referred to individually, as a “Party” and collectively, as the “Parties”).

Biolase Technology Inc – AGREEMENT (July 7th, 2010)

This Agreement (this “Agreement”) is made and entered into as of July 1, 2010 (the “Effective Date”), by and among BIOLASE Technology, Inc., a Delaware corporation (the “Company”), Federico Pignatelli (“Mr. Pignatelli”), and each of David Mulder, George d’Arbeloff, Robert Anderton, James Largent and Gregory Waller (collectively, the “Other Directors,” and together with Mr. Pignatelli, the “Directors”) in each of the Directors’ respective capacities as an individual and as a director of the Company, and Brett Scott, the Company’s Chief Financial Officer, and Michael Carroll, the Company’s General Counsel, both in their respective capacities as an individual and officer of the Company (collectively, the “Officers”). Each of the Company, the Directors and the Officers are referred to herein as a “Party,” and collectively as the “Parties”.

Biolase Technology Inc – HENRY SCHEIN, INC. (May 17th, 2010)

This letter agreement shall serve to amend that certain License and Distribution Agreement, by and between Henry Schein, Inc. (“HSIC”) and Biolase Technology, Inc. (“Biolase”), dated as of August 8, 2006, as amended (the “Agreement”).

Biolase Technology Inc – BIOLASE AND HENRY SCHEIN EXTEND AND AMEND LICENSING AND DISTRIBUTION AGREEMENT BIOLASE Announces Preliminary 2009 Fourth Quarter Results (March 11th, 2010)

IRVINE, CA (March 10, 2010) – BIOLASE Technology, Inc. (NASDAQ: BLTI), the world’s leading dental laser company, announced today that it has amended its licensing and distribution agreement with Henry Schein, Inc. (NASDAQ: HSIC), the largest provider of healthcare products and services to office-based practitioners. Within the United Kingdom, Australia, New Zealand, Belgium, Luxembourg, Netherlands, Spain, Germany, Italy, Austria, and North America, all dental sales will continue to be provided exclusively through Henry Schein. The amended agreement provides strong incentives for Henry Schein to focus on its core customer base, and the purchase minimums have been agreed based upon that focus. In addition to the Henry Schein core customer base, BIOLASE will have strong incremental sales and margin incentives to penetrate additional dental offices. The agreement also allows for higher sales organization incentives, unique financing programs and increased luminary and educational events.

Biolase Technology Inc – [LETTERHEAD OF HENRY SCHEIN, INC.] (May 8th, 2009)

This letter agreement shall serve to amend that certain License and Distribution Agreement, by and between Henry Schein, Inc. (“HSI”) and Biolase Technology, Inc, (“Biolase”), dated as of August 8, 2006, as amended (the “Agreement”).

Biolase Technology Inc – Biolase Technology, Inc. 4 Cromwell Irvine, California 92618 (May 8th, 2009)

This letter agreement shall serve to amend that certain Employment Agreement, dated April 29, 2008 (the “Employment Agreement”), by and between Biolase Technology, Inc. (the “Company”) and David M. Mulder.

Biolase Technology Inc – BIOLASE REPORTS FOURTH QUARTER, YEAR-END RESULTS Financial Restructuring in Full Effect by Q2; Quarterly Cash Breakeven Target Aligned with New Minimum Purchase Agreement (March 16th, 2009)

IRVINE, CA (March 16, 2009) — BIOLASE Technology, Inc. (NASDAQ:BLTI), the world’s leading dental laser company, today reported operating results for its fourth quarter and year ended December 31, 2008.

Biolase Technology Inc – EMPLOYMENT AGREEMENT (August 8th, 2008)

EMPLOYMENT AGREEMENT (the “Agreement”) made as of the 29th day of April, 2008 by and between Biolase Technology, Inc. (the “Company”) and David M. Mulder (“Executive”).